IMCR — Immunocore Holdings plc stock price, charts and financials

QT46Immunocore Holdings plc

Immunocore Holdings plc (NASDAQ: IMCR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
33.24
+0.81+2.50%
OverviewShort InterestFilings
IMCRQT46Immunocore Holdings plc·NASDAQ
33.24+2.50%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 27, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 08, 2026S-8Registration of employee benefit securities
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 16, 2026DEF 14ADefinitive proxy statement
Apr 16, 2026ARSAnnual report to shareholders
Mar 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 25, 202610-KAnnual report
Feb 25, 20268-KCurrent report
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 19, 20264Statement of changes in beneficial ownership
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 30, 20268-KCurrent report
Jan 09, 20268-KCurrent report
#1 / 25 of 210
Page
▼
/ 9